Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:ATCCode |
none
|
| gptkbp:binding_target |
gptkb:5-HT1A_receptor
|
| gptkbp:CASNumber |
135558-11-1
|
| gptkbp:category |
gptkb:piperazine
phenol ether pyridine derivative |
| gptkbp:chemicalFormula |
C21H23ClN2O
|
| gptkbp:developedBy |
gptkb:Wyeth-Ayerst
|
| gptkbp:effect |
benzodiazepine
antipsychotic medication antidepressant |
| https://www.w3.org/2000/01/rdf-schema#label |
WAY-100635
|
| gptkbp:IUPACName |
N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexanecarboxamide
|
| gptkbp:molecularWeight |
370.87 g/mol
|
| gptkbp:PubChem_CID |
104741
CHEMBL33314 |
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:synonym |
WAY 100635
WAY-100,635 |
| gptkbp:UNII |
1H2V2V43WF
|
| gptkbp:used_in |
neuroscience research
PET imaging |
| gptkbp:usedFor |
5-HT1A receptor antagonist
radioligand (when labeled with carbon-11 or fluorine-18) |
| gptkbp:bfsParent |
gptkb:5-HT1_receptor
|
| gptkbp:bfsLayer |
7
|